Consensus Zimmer Biomet Holdings, Inc.

Equities

ZBH

US98956P1021

Market Closed - Nyse Other stock markets 04:00:01 2024-04-18 pm EDT			5-day change	1st Jan Change
119.3 ^USD	-1.62%		-6.42%	-1.95%

Apr. 15	Truist Securities Adjusts Zimmer Biomet Price Target to $137 From $135, Hold Rating Kept	MT
Apr. 04	Zimmer Biomet Partners with Three Pickleball Organizations in US	MT

Evolution of the average Target Price on Zimmer Biomet Holdings, Inc.

Price target over the last 5 years

History of analyst recommendation changes

233ef10467c54.7PJHXWElhyS8SlO8K_ZTyfqS7SGo9kzln1OqhUPQoXw.j5shLDtO8xHvJAD-XodkhY7KqW7SkT2Q9DrQ4Srl9UyChwYkLUDOY98cAg~d4a255f4d2a49ad5112f3019ef7fd851

Analyst Recommendations on Zimmer Biomet Holdings, Inc.

Truist Securities Adjusts Zimmer Biomet Price Target to $137 From $135, Hold Rating Kept	Apr. 15	MT
Citigroup Raises Price Target on Zimmer Biomet to $140 From $134, Keeps Neutral Rating	Apr. 03	MT
UBS Adjusts Zimmer Biomet Price Target to $109 From $105, Maintains Sell Rating	Feb. 09	MT
Deutsche Bank Adjusts Zimmer Biomet Price Target to $140 From $147, Maintains Hold Rating	Feb. 09	MT
UBS Raises Zimmer Biomet Price Target to $105 From $99, Maintains Sell Rating	Jan. 22	MT
RBC Raises Price Target on Zimmer Biomet Holdings to $140 From $134, Keeps Outperform Rating	Jan. 12	MT
Evercore ISI Downgrades Zimmer Biomet to In Line From Outperform, Adjusts Price Target to $125 From $135	Jan. 04	MT
Raymond James Raises Zimmer Biomet's Price Target to $137 From $133, Maintains Outperform Rating	Jan. 03	MT
Truist Adjusts Price Target on Zimmer Biomet Holdings to $133 From $115, Maintains Hold Rating	Dec. 22	MT
Euphoria subsides for Triple-Witching Day	Dec. 15
ANALYST RECOMMENDATIONS : Adobe, Blackrock, Roblox, Snap, US Bancorp...	Dec. 15
Morgan Stanley Raises Zimmer Biomet Price Target to $125 From $120, Maintains Equal Weight Rating	Dec. 04	MT
JMP Securities Adjusts Price Target on Zimmer Biomet Holdings to $140 From $160, Maintains Market Outperform Rating	Nov. 13	MT
Raymond James Adjusts Price Target on Zimmer Biomet to $133 From $160, Maintains Outperform Rating	Nov. 09	MT
Another clue on monetary policy?	Nov. 08
ANALYST RECOMMENDATIONS : AMD, Chevron, Ebay, Quanta Services, UPS...	Nov. 08
UBS Cuts Price Target on Zimmer Biomet to $100 From $125, Keeps Sell Rating	23-10-16	MT
Citigroup Cuts Zimmer Biomet's Price Target to $125 From $146, Maintains Neutral Rating	23-10-02	MT
Out with the old	23-10-02
ANALYST RECOMMENDATIONS : Amgen, Best Buy, Comcast, Fedex, Mosaic...	23-10-02
BTIG Upgrades Zimmer Biomet to Buy From Neutral, Price Target is $139	23-08-28	MT
UBS Adjusts Zimmer Biomet Price Target to $125 From $116, Maintains Sell Rating	23-08-02	MT
Barclays Adjusts Zimmer Biomet Price Target to $120 From $116, Maintains Underweight Rating	23-08-02	MT
Zimmer Biomet Holdings Q2 Adjusted Earnings Flat, Sales Increase; Raises Guidance	23-08-01	MT
Truist Securities Adjusts Price Target on Zimmer Biomet to $153 From $147, Maintains Hold Rating	23-07-19	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

119.3 USD

Average target price

137.1 USD

Spread / Average Target

+14.93%

High Price Target

175 USD

Spread / Highest target

+46.65%

Low Price Target

109 USD

Spread / Lowest Target

-8.66%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Zimmer Biomet Holdings, Inc.

Truist Securities
Citigroup
UBS
Deutsche Bank Securities
RBC Capital Markets
Evercore ISI
Raymond James
Morgan Stanley
JMP Securities
BTIG
Barclays
Stifel Nicolaus
JPMorgan Chase
Bernstein
Baird
BofA Securities
Jefferies & Co.
Piper Sandler
Oppenheimer
Wells Fargo Securities
Goldman Sachs
Needham & Co.
SVB Leerink
Guggenheim
Loop Capital
Canaccord Genuity
Argus
Ned Davis Research
J.P. Morgan Chase
Northland Securities

Ratings for Zimmer Biomet Holdings, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar